Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current assets
Cash	$ 8,273,728	$ 16,808,539
Prepaid research and development	767,650	66,217
Other current assets	237,158	244,021
Total current assets	9,278,536	17,118,777
Deposits	127,534	127,534
Property and equipment, net	20,531	16,377
Right of use asset	482,986	638,786
Total assets	9,909,587	17,901,474
Current liabilities
Accounts payable	420,353	953,349
Accrued expenses	1,408,968	850,557
Lease liability, current portion	341,308	332,817
Short-term milestone payable due to Patagonia Pharmaceuticals, LLC	2,250,000
Redeemable Series A preferred stock under redemption (Note 5)	2,151,675	2,055,348
Total current liabilities	6,572,304	4,192,071
Note payable		37,772
Lease liability	163,985	331,152
Long-term milestone payable due to Patagonia Pharmaceuticals, LLC	1,750,000
Other liabilities	73,683	73,683
Total liabilities	8,559,972	4,634,678
Commitments and contingencies (Note 7)
Stockholders' equity
Common stock, par value $0.001; 450,000,000 shares authorized; 63,753,834 shares issued and outstanding as of June 30, 2022, and 63,619,140 shares issued and outstanding as of December 31, 2021	63,754	63,619
Additional paid-in capital	42,739,793	42,087,719
Accumulated deficit	(41,453,932)	(28,884,542)
Total stockholders' equity	1,349,615	13,266,796
Total liabilities and stockholders' equity	$ 9,909,587	$ 17,901,474